A De Novo Mutation in COL1A1 in a Holstein Calf with Osteogenesis Imperfecta Type II

被引:2
|
作者
Jacinto, Joana G. P. [1 ,2 ]
Haefliger, Irene M. [2 ]
McEvoy, Fintan J. [3 ]
Droegemueller, Cord [2 ]
Agerholm, Jorgen S. [3 ]
机构
[1] Univ Bologna, Dept Vet Med Sci, I-40064 Ozzano Dell Emilia, Italy
[2] Univ Bern, Vetsuisse Fac, Inst Genet, CH-3012 Bern, Switzerland
[3] Univ Copenhagen, Dept Vet Clin Sci, Dyrlaegevej 16, DK-1870 Copenhagen, Denmark
来源
ANIMALS | 2021年 / 11卷 / 02期
基金
瑞士国家科学基金会;
关键词
cattle; Bos taurus; collagenopathy; skeletal disorder; bone disease; rare diseases; precision medicine; whole-genome sequencing;
D O I
10.3390/ani11020561
中图分类号
S8 [畜牧、 动物医学、狩猎、蚕、蜂];
学科分类号
0905 ;
摘要
Simple Summary Skeletal connective tissue disorders represent a heterogeneous group of inherited disorders mostly monogenically inherited. Heritable connective tissue disorders such as osteogenesis imperfecta (OI) belong to this group. Herein, an affected calf showing congenital bone lesions such as intrauterine fractures, abnormally shaped long bones and localized arthrogryposis resembling OI type II is reported. Whole-genome sequencing (WGS) identified a most likely disease-causing mutation in the COL1A1 gene. The COL1A1 gene is known to be associated with dominant inherited OI type II forms in humans and sporadically in dogs and cattle, but so far, a variant in the fibrillar collagen NC1 domain has not been shown to cause a similar phenotype in domestic animals. We assume that the herein identified most-likely causative variant occurred either within the parental germlines or post-zygotically in the developing embryo. Rare lethal disorders such as OI in livestock are usually not diagnosed to the molecular level, mainly because of the lack of resources and diagnostic tools. WGS-based precision diagnostics allows understanding rare disorders and supports the value of surveillance of cattle breeding populations for harmful genetic disorders. Osteogenesis imperfecta (OI) type II is a genetic connective tissue disorder characterized by bone fragility, severe skeletal deformities and shortened limbs. OI usually causes perinatal death of affected individuals. OI type II diagnosis in humans is established by the identification of heterozygous mutations in genes coding for collagens. The purpose of this study was to characterize the pathological phenotype of an OI type II-affected neonatal Holstein calf and to identify the causative genetic variant by whole-genome sequencing (WGS). The calf had acute as well as intrauterine fractures, abnormally shaped long bones and localized arthrogryposis. Genetic analysis revealed a private heterozygous missense variant in COL1A1 (c.3917T>A) located in the fibrillar collagen NC1 domain (p.Val1306Glu) that most likely occurred de novo. This confirmed the diagnosis of OI type II and represents the first report of a pathogenic variant in the fibrillar collagen NC domain of COL1A1 associated to OI type II in domestic animals. Furthermore, this study highlights the utility of WGS-based precise diagnostics for understanding congenital disorders in cattle and the need for continued surveillance for rare lethal genetic disorders in cattle.
引用
收藏
页码:1 / 9
页数:8
相关论文
共 50 条
  • [41] Mutations in COL1A1 of Type I Collagen Genes in Chinese Patients With Osteogenesis Imperfecta
    Wang, Zhuo
    Yang, Zheng
    Ke, Zunfu
    Yang, Shicong
    Shi, Huijuan
    Wang, Liantang
    JOURNAL OF INVESTIGATIVE MEDICINE, 2009, 57 (05) : 662 - 667
  • [42] Osteosclerotic variant of osteogenesis imperfecta with a mutation in the C-propeptide region of COL1A1 gene
    Hori, Naoaki
    Nishimura, Gen
    Takagi, Masaki
    Chinen, Yasutsugu
    Kurosawa, Kenji
    Tanaka, Yukichi
    Oku, Kikuko
    Hasegawa, Tomonobu
    HORMONE RESEARCH, 2009, 72 : 223 - 224
  • [43] Insight into the Pathology of a COL1A1 Signal Peptide Heterozygous Mutation Leading to Severe Osteogenesis Imperfecta
    Lindert, U.
    Gnoli, M.
    Maioli, M.
    Bedeschi, M. F.
    Sangiorgi, L.
    Rohrbach, M.
    Giunta, C.
    CALCIFIED TISSUE INTERNATIONAL, 2018, 102 (03) : 373 - 379
  • [44] Three Patient Kindred with Novel Phenotype of Osteogenesis Imperfecta due to a Mutation in the COL1A1 gene
    Gupta, Nidhi
    Gregory, Seth
    Deyle, David
    Tebben, Peter
    JOURNAL OF BONE AND MINERAL RESEARCH, 2018, 33 : 333 - 333
  • [45] Mutation analysis in the COL1A1 gene in osteogenesis imperfecta patients from the Republic of Sakha (Yakutia)
    Khusainova, R., I
    Nadyrshina, D. D.
    Gilyazova, I. R.
    Alekseeva, S. P.
    Nogovitsyna, A.
    Sukhomyasova, A. L.
    Fedorova, S. A.
    Khusnutdinova, E. K.
    YAKUT MEDICAL JOURNAL, 2012, (03): : 63 - 70
  • [46] A missense mutation in Col1A1 in a Jewish Israeli patient with mild osteogenesis imperfecta, detected by DGGE
    GatYablonski, G
    Ries, L
    Lev, D
    Goldman, B
    Friedman, E
    HUMAN GENETICS, 1997, 101 (01) : 22 - 25
  • [47] Insight into the Pathology of a COL1A1 Signal Peptide Heterozygous Mutation Leading to Severe Osteogenesis Imperfecta
    U. Lindert
    M. Gnoli
    M. Maioli
    M.F. Bedeschi
    L. Sangiorgi
    M. Rohrbach
    C. Giunta
    Calcified Tissue International, 2018, 102 : 373 - 379
  • [48] A novel mild variant of osteogenesis imperfecta type I caused by a Gly1088Glu mutation in COL1A1
    Xia, Xin-Yi
    Li, Wei-Wei
    Li, Na
    Wu, Qiu-Yue
    Cui, Ying-Xia
    Li, Xiao-Jun
    MOLECULAR MEDICINE REPORTS, 2014, 9 (06) : 2187 - 2190
  • [49] Prenatal diagnosis of a novel COL1A1 mutation in osteogenesis imperfecta type I carried through full term pregnancy
    Ries, L
    Frydman, M
    Barkai, G
    Goldman, B
    Friedman, E
    PRENATAL DIAGNOSIS, 2000, 20 (11) : 876 - 880
  • [50] A novel RNA-splicing mutation in COL1A1 gene causing osteogenesis imperfecta type I in a Chinese family
    Xia, Xin-Yi
    Cui, Ying-Xia
    Huang, Yu-Feng
    Pan, Lian-Jun
    Yang, Bin
    Wang, Hao-Yang
    Li, Xiao-Jun
    Shi, Yi-Chao
    Lu, Hong-Yong
    Zhou, Yu-Chun
    CLINICA CHIMICA ACTA, 2008, 398 (1-2) : 148 - 151